Telmisartan in Combination with Different Drugs for Mild to Moderate Essential Hypertension:Cost-Effectiveness Analysis / 中国药房
China Pharmacy
;
(12)2007.
Artigo
em Chinês
| WPRIM
| ID: wpr-529806
ABSTRACT
OBJECTIVE:
To evaluate the cost-effectiveness of telmisartan in combination with different drugs in the trea-tment of mild to moderate essential hypertension.METHODS:
A total of 60 patients were enrolled and randomized to Group A(telmisartan+felodipine),Group B(telmisartan+enalapril),or Group C(telmisartan+indapamide).A cost-effectiveness analysis of the three therapeutic schemes was conducted after 8-wk treatment.RESULTS:
The effective rates of three Groups were 90%,85% and 95%,respectively;the total costs of three groups were 422.80,409.50 and 348.88 yuan,respectively,with Group C showing significant difference as compared with the other two groups(Group B and Group C)(P
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Ensaio Clínico Controlado
/
Avaliação Econômica em Saúde
Idioma:
Chinês
Revista:
China Pharmacy
Ano de publicação:
2007
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS